{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:26:03Z","timestamp":1784186763048,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22 A20525"],"award-info":[{"award-number":["U22 A20525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202410367063"],"award-info":[{"award-number":["202410367063"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022 A1515140038"],"award-info":[{"award-number":["2022 A1515140038"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.146101","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:23:11Z","timestamp":1752765791000},"page":"146101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P4","title":["Self-assembled ferritin tuberculosis nanovaccines targeting ESAT-6 and CFP-10 elicit potent immunogenicity in mice"],"prefix":"10.1016","volume":"320","author":[{"given":"Fangzheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wutong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.146101_bb0005","article-title":"Tuberculosis prevention: current strategies and future directions","author":"Vasiliu","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41467-023-44252-5","article-title":"BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination","volume":"15","author":"van Meijgaarden","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41541-023-00750-7","article-title":"Key advances in vaccine development for tuberculosis-success and challenges","volume":"8","author":"Lai","year":"2023","journal-title":"NPJ Vaccines."},{"issue":"6 Pt 2","key":"10.1016\/j.ijbiomac.2025.146101_bb0020","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1542\/peds.86.6.1060","article-title":"The national immunization program of the Netherlands","volume":"86","author":"Verbrugge","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1032385","article-title":"Public health impact and return on investment of Belgium\u2019s pediatric immunization program","volume":"11","author":"Carrico","year":"2023","journal-title":"Front. Public Health"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146101_bb0030","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/cid\/ciz1080","article-title":"Early vaccination with Bacille Calmette-Gu\u00e9rin-Denmark or BCG-Japan versus BCG-Russia to healthy newborns in Guinea-Bissau: arandomized controlled trial","volume":"71","author":"Schaltz-Buchholzer","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/imr.12968","article-title":"A century of BCG: impact on tuberculosis control and beyond","volume":"301","author":"Ahmed","year":"2021","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146101_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clim.2007.07.007","article-title":"Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice","volume":"125","author":"Kalra","year":"2007","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146101_bb0045","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/iai.63.5.1710-1717.1995","article-title":"Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis","volume":"63","author":"S\u00f8rensen","year":"1995","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/iai.64.1.16-22.1996","article-title":"Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG","volume":"64","author":"Harboe","year":"1996","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146101_bb0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-3083.2007.02006.x","article-title":"DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice","volume":"66","author":"Fan","year":"2007","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146101_bb0060","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/jam.13449","article-title":"Lactococcus lactis carrying a DNA vaccine coding for the ESAT-6 antigen increases IL-17 cytokine secretion and boosts the BCG vaccine immune response","volume":"122","author":"Pereira","year":"2017","journal-title":"J. Appl. Microbiol."},{"issue":"Pt 11","key":"10.1016\/j.ijbiomac.2025.146101_bb0065","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1099\/00221287-144-11-3195","article-title":"A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)","volume":"144","author":"Berthet","year":"1998","journal-title":"Microbiology (Reading)."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146101_bb0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2958.2007.05959.x","article-title":"A unique Mycobacterium ESX-1 protein co-secretes with CFP-10\/ESAT-6 and is necessary for inhibiting phagosome maturation","volume":"66","author":"Xu","year":"2007","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.68.1.214-220.2000","article-title":"Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens","volume":"68","author":"Skj\u00f8t","year":"2000","journal-title":"Infect. Immun."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.146101_bb0080","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1016\/j.vaccine.2007.03.052","article-title":"An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis","volume":"25","author":"Maue","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0085","article-title":"Optimizing the boosting schedule of subunit vaccines consisting of BCG and \u201cnon-BCG\u201d antigens to induce long-term immune memory","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146101_bb0090","article-title":"First-in-human trials of GamTBvac, a recombinant subunit tuberculosis vaccine candidate: safety and immunogenicity assessment","volume":"7","author":"Vasina","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146101_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040652","article-title":"Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: a phase II, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146101_bb0100","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/C9NR08958F","article-title":"Nanoparticle formulated vaccines: opportunities and challenges","volume":"12","author":"Lung","year":"2020","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146101_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000087","article-title":"Self-assembled nanoparticles: exciting platforms for vaccination","volume":"15","author":"Pan","year":"2020","journal-title":"Biotechnol. J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146101_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110514","article-title":"mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice","volume":"38","author":"Mu","year":"2022","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146101_bb0115","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/acsinfecdis.7b00192","article-title":"Two-component ferritin nanoparticles for Multimerization of diverse trimeric antigens","volume":"4","author":"Georgiev","year":"2018","journal-title":"ACS Infect Dis."},{"issue":"7456","key":"10.1016\/j.ijbiomac.2025.146101_bb0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0125","doi-asserted-by":"crossref","unstructured":"Nie J, Zhou Y, Ding F, et al. Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice. Int. J. Biol. Macromol. doi:https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129259.","DOI":"10.1016\/j.ijbiomac.2024.129259"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146101_bb0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41541-021-00414-4","article-title":"SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses","volume":"6","author":"Carmen","year":"2021","journal-title":"NPJ Vaccines."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146101_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110143","article-title":"SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity","volume":"37","author":"Joyce","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146101_bb0145","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0150","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156610","article-title":"Immune responses induced by Mycobacterium tuberculosis heat-resistant antigen (Mtb-HAg) upon co-administration with Bacillus Calmette-Gu\u00e9rin in mice","volume":"179","author":"Guo","year":"2024","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s11658-024-00585-7","article-title":"Analysis of the components of Mycobacterium tuberculosis heat-resistant antigen (Mtb-HAg) and its regulation of \u03b3\u03b4 T-cell function","volume":"29","author":"Wei","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146101_bb0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122161119","article-title":"The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence","volume":"119","author":"Osman","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146101_bb0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.34172\/bi.2022.23645","article-title":"CFP10-loaded PLGA nanoparticles as a booster vaccine confer protective immunity against Mycobacterium bovis","volume":"12","author":"Liang","year":"2022","journal-title":"Bioimpacts"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146101_bb0175","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","article-title":"Principles and therapeutic applications of adaptive immunity","volume":"187","author":"Chi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-0716-3754-8_17","article-title":"Assessing antigen-specific T cell responses through IFN-\u03b3 enzyme-linked immune absorbent spot (ELISpot)","volume":"2782","author":"van Freen- Heeren","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2018.00532","article-title":"Neonatal immunization: rationale, current state, and future prospects","volume":"9","author":"Whittaker","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146101_bb0190","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/acsinfecdis.0c00696","article-title":"BCG vaccination of infants confers Mycobacterium tuberculosis strain-specific immune responses by leukocytes","volume":"6","author":"Subbian","year":"2020","journal-title":"ACS Infect Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146101_bb0195","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Gu\u00e9rin vaccination at first health center contact","volume":"31","author":"Biering-S\u00f8rensen","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146101_bb0200","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: arandomized controlled trial","volume":"65","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0205","doi-asserted-by":"crossref","first-page":"15309","DOI":"10.1038\/s41598-018-33499-4","article-title":"Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries","volume":"8","author":"Whittaker","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146101_bb0210","first-page":"205","article-title":"The geographic location (latitude) of studies evaluating protective effect of BCG vaccine and it\u2019s efficacy\/effectiveness against tuberculosis","volume":"51","author":"Zodpey","year":"2007","journal-title":"Indian J. Public Health"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146101_bb0215","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2249.2006.03222.x","article-title":"The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Gu\u00e9rin vaccination in southern England and northern Malawi","volume":"146","author":"Weir","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146101_bb0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat. Med."},{"issue":"9493","key":"10.1016\/j.ijbiomac.2025.146101_bb0225","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146101_bb0230","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung","year":"2001","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146101_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114602","article-title":"Safety and immunogenicity of H1\/IC31\u00ae, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells\/mm3: a phase II, multi-Centre, double-blind, randomized, placebo-controlled trial","volume":"9","author":"Reither","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146101_bb0240","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.201802-0366OC","article-title":"Dose optimization of H56:IC31 vaccine for tuberculosis-endemic populations. A double-blind, placebo-controlled, dose-selection trial","volume":"199","author":"Suliman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146101_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176784","article-title":"Multi-subunit BCG booster vaccine GamTBvac: assessment of immunogenicity and protective efficacy in murine and guinea pig TB models","volume":"12","author":"Tkachuk","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608220","article-title":"Age-related immunoreactivity profiles to diverse mycobacterial antigens in BCG-vaccinated Chinese population","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"issue":"Pt 12","key":"10.1016\/j.ijbiomac.2025.146101_bb0255","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1107\/S1744309110042958","article-title":"Crystallization and preliminary X-ray crystallographic analysis of a Mycobacterium tuberculosis ferritin homolog, BfrB","volume":"66","author":"McMath","year":"2010","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0260","article-title":"Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE. Preprint","author":"Liu","year":"2024","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146101_bb0265","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1074\/mcp.RA117.000296","article-title":"Systematic identification of Mycobacterium tuberculosis effectors reveals that BfrB suppresses innate immunity","volume":"16","author":"He","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0270","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1146\/annurev-immunol-093019-125148","article-title":"The tuberculous granuloma and preexisting immunity","volume":"40","author":"Cohen","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1427846","article-title":"Host and pathogen genetic diversity shape vaccine-mediated protection to Mycobacterium tuberculosis","volume":"15","author":"Cohen","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146101_bb0280","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-021-01229-0","article-title":"Self-assembling ferritin nanoparticles coupled with linear sequences from canine distemper virus haemagglutinin protein elicit robust immune responses","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146101_bb0290","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/imcb.12275","article-title":"The generation of T-cell memory to protect against tuberculosis","volume":"97","author":"Counoupas","year":"2019","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146101_bb0295","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.immuni.2016.11.009","article-title":"CD8+ T cells utilize highly dynamic enhancer repertoires and regulatory circuitry in response to infections","volume":"45","author":"He","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146101_bb0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"Orme","year":"2010","journal-title":"Tuberculosis (Edinb.)"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146101_bb0305","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"Lindenstr\u00f8m","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02350","article-title":"IL-2 restores T-cell dysfunction induced by persistent Mycobacterium tuberculosis antigen stimulation","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"issue":"45","key":"10.1016\/j.ijbiomac.2025.146101_bb0315","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1016\/j.vaccine.2020.08.004","article-title":"BCG-prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis","volume":"38","author":"Tiwari","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2017.10.014","article-title":"Evaluation of profile and functionality of memory T cells in pulmonary tuberculosis","volume":"192","author":"Tonaco","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100313","article-title":"A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa","volume":"21","author":"Bekker","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146101_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008356","article-title":"Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells","volume":"16","author":"Ahmad","year":"2020","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146101_bb0335","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/infdis\/jiad214","article-title":"Cotreatment with Clofazimine and rapamycin eliminates drug-resistant tuberculosis by inducing Polyfunctional central memory T-cell responses","volume":"228","author":"Singh","year":"2023","journal-title":"J. Infect. Dis."},{"issue":"33","key":"10.1016\/j.ijbiomac.2025.146101_bb0340","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146101_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007643","article-title":"A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates","volume":"15","author":"Rodo","year":"2019","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0350","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.medmal.2019.09.012","article-title":"Aluminum and vaccines: current state of knowledge","volume":"50","author":"Goull\u00e9","year":"2020","journal-title":"Med. Mal. Infect."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0355","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2022.2150449","article-title":"Pathogenicity and virulence of Mycobacterium tuberculosis","volume":"14","author":"Rahlwes","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.ijbiomac.2025.146101_bb0360","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146101_bb0365","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1084\/jem.20052545","article-title":"Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection","volume":"203","author":"Khader","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0370","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis","volume":"186","author":"Cooper","year":"1997","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146101_bb0375","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mi.2011.13","article-title":"Role of innate cytokines in mycobacterial infection","volume":"4","author":"Cooper","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146101_bb0380","article-title":"IL-17A synergizes with IFN-\u03b3 to upregulate iNOS and NO production and inhibit chlamydial growth","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146101_bb0385","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146101_bb0390","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20110919","article-title":"Regulation of neutrophils by interferon-\u03b3 limits lung inflammation during tuberculosis infection","volume":"208","author":"Nandi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0395","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.192.1.117","article-title":"Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells","volume":"192","author":"Dalton","year":"2000","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146101_bb0400","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1084\/jem.20020666","article-title":"Interferon gamma is required for activation-induced death of T lymphocytes","volume":"196","author":"Refaeli","year":"2002","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146101_bb0405","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/eji.201141569","article-title":"IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination","volume":"42","author":"Gopal","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146101_bb0410","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.201040433","article-title":"Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung","volume":"40","author":"Redford","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146101_bb0415","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1128\/IAI.00550-12","article-title":"Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset","volume":"80","author":"Lindenstr\u00f8m","year":"2012","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146101_bb0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41541-020-00255-7","article-title":"Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis","volume":"5","author":"Counoupas","year":"2020","journal-title":"NPJ Vaccines."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146101_bb0425","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146101_bb0430","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00109-021-02100-3","article-title":"Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA\/TDB independently of interleukin-17A","volume":"99","author":"Ritter","year":"2021","journal-title":"J. Mol. Med. (Berl)"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025066589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025066589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:40:51Z","timestamp":1777192851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025066589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":86,"alternative-id":["S0141813025066589"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146101","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled ferritin tuberculosis nanovaccines targeting ESAT-6 and CFP-10 elicit potent immunogenicity in mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"146101"}}